Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15055305 | 1.00 | PTGS1 (0.30) | PTGS1AKR1C3 | |
| SCHEMBL1286855 | 0.85 | EP300 (0.38) | — | |
| SCHEMBL1286854 | 0.85 | EP300 (0.38) | — | |
| SCHEMBL3260181 | 0.81 | PTGS1 (0.32) | PTGS1AKR1C3 | |
| SCHEMBL3260179 | 0.81 | PTGS1 (0.32) | PTGS1AKR1C3 | |
| SCHEMBL1228722 | 0.80 | FDPS (0.32) | — | |
| SCHEMBL3232588 | 0.80 | ALDH1A1 (0.31) | — | |
| SCHEMBL3232596 | 0.80 | ALDH1A1 (0.31) | — | |
| SCHEMBL6026915 | 0.77 | — | — | |
| SCHEMBL6026913 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10669475-B2 | Surface modified nanoparticles | Nanco Technologies Ltd. (GB) | 2020-06-02 | — | — | US | claimed |
| EP-2794464-B1 | SURFACE MODIFIED NANOPARTICLES | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-11-22 | — | — | EP | disclosed |
| WO-2022013535-A1 | METHOD FOR THE DETECTION OF SURFACE-MOUNTED BIOLOGICAL PATHOGENS | NANOCO TECHNOLOGIES LTD (GB) | 2022-01-20 | — | — | WO | disclosed |
| US-20220018837-A1 | Method for the Detection of Surface-Mounted Biological Materials and Pathogens | NANOCO TECHNOLOGIES LTD. (GB) | 2022-01-20 | — | — | US | disclosed |
| US-11053436-B2 | Surface modified nanoparticles | Nanoco Technologies, Ltd. (GB) | 2021-07-06 | — | — | US | disclosed |
| US-20210190775-A1 | COMPOSITIONS AND METHODS FOR TAGGING AND DETECTING NUCLEIC ACIDS | NANOCO TECHNOLOGIES LTD. (GB) | 2021-06-24 | — | — | US | disclosed |
| US-20200306377-A1 | METHODS FOR ENHANCING 5-AMINOLEVULINIC ACID-BASED MEDICAL IMAGING AND PHOTOTHERAPY | NANOCO TECHNOLOGIES LTD (GB) | 2020-10-01 | — | — | US | disclosed |
| EP-3697443-A1 | METHODS FOR ENHANCING 5-AMINOLEVULINIC ACID-BASED MEDICAL IMAGING AND PHOTOTHERAPY | Nanoco Technologies Ltd (GB) | 2020-08-26 | — | — | EP | disclosed |
| US-20200263086-A1 | SURFACE MODIFIED NANOPARTICLES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-08-20 | — | — | US | disclosed |
| US-20200197520-A1 | LIGHT RESPONSIVE QUANTUM DOT DRUG DELIVERY SYSTEM | NANOCO TECHNOLOGIES LTD (GB) | 2020-06-25 | — | — | US | disclosed |
| US-20180009659-A1 | LIGAND CONJUGATED QUANTUM DOT NANOPARTICLES AND METHODS OF DETECTING DNA METHYLATION USING SAME | NANOCO TECHNOLOGIES LIMITED (GB) | 2018-01-11 | — | — | US | disclosed |
| WO-2018007800-A1 | LIGAND CONJUGATED QUANTUM DOT NANOPARTICLES AND METHODS OF DETECTING DNA METHYLATION USING SAME | NANOCO TECHNOLOGIES LTD (GB) | 2018-01-11 | — | — | WO | disclosed |
| US-20180011346-A1 | PROBE FOR TARGETING AND MANIPULATING MITOCHONDRIAL FUNCTION USING QUANTUM DOTS | NANOCO TECHNOLOGIES LIMITED (GB) | 2018-01-11 | — | — | US | disclosed |
| WO-2018007801-A1 | A PROBE FOR TARGETING AND MANIPULATING MITOCHONDRIAL FUNCTION USING QUANTUM DOTS | NANOCO TECHNOLOGIES LTD (GB) | 2018-01-11 | — | — | WO | disclosed |
| US-9840664-B2 | Surface modified nanoparticles | NANOCO TECHNOLOGIES LTD. (GB) | 2017-12-12 | — | — | US | disclosed |
| US-20160046859-A1 | Surface Modified Nanoparticles | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-02-18 | — | — | US | disclosed |
| US-9115097-B2 | Surface modified nanoparticles | NANOCO TECHNOLOGIES LTD. (GB) | 2015-08-25 | — | — | US | disclosed |
| EP-2794464-A2 | SURFACE MODIFIED NANOPARTICLES | Nanoco Technologies Limited (GB) | 2014-10-29 | — | — | EP | disclosed |
| US-20130190493-A1 | Surface Modified Nanoparticles | Nanoco Technologies, Ltd. (GB) | 2013-07-25 | — | — | US | disclosed |
| WO-2013093631-A2 | SURFACE MODIFIED NANOPARTICLES | NANOCO TECHNOLOGIES, INC. (GB) | 2013-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130190493-A1 | Surface Modified Nanoparticles | PNMT, CD14, OPRM1 | PTGS1 2675/4885AKR1C3 4528/4885 |
| US-20180011346-A1 | PROBE FOR TARGETING AND MANIPULATING MITOCHONDRIAL FUNCTION USING QUANTUM DOTS | NDUFAB1, UQCRC2, MT-ND2 | PTGS1 3678/4885AKR1C3 4377/4885 |
| US-20160046859-A1 | Surface Modified Nanoparticles | PNMT, CD14, OPRM1 | PTGS1 2675/4885AKR1C3 4528/4885 |
| US-10669475-B2 | Surface modified nanoparticles | PNMT, CD14, OPRM1 | PTGS1 2675/4885AKR1C3 4528/4885 |
| US-20200306377-A1 | METHODS FOR ENHANCING 5-AMINOLEVULINIC ACID-BASED MEDICAL IMAGING AND PHOTOTHERAPY | ALAD, AADAT, SLC1A5 | PTGS1 2049/4885AKR1C3 3714/4885 |
| US-11053436-B2 | Surface modified nanoparticles | SELPLG, EPCAM, NAPA | PTGS1 1436/4885AKR1C3 4060/4885 |
| US-20200263086-A1 | SURFACE MODIFIED NANOPARTICLES | SELPLG, EPCAM, NAPA | PTGS1 1436/4885AKR1C3 4060/4885 |
| US-20200197520-A1 | LIGHT RESPONSIVE QUANTUM DOT DRUG DELIVERY SYSTEM | HCCS, STRA6, CRY2 | PTGS1 1406/4885AKR1C3 4284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.